TLR4/IL-6/IRF1 signaling regulates androgen receptor expression: A potential therapeutic target to overcome taxol resistance in ovarian cancer
Author:
Funder
Chang Gung Memorial Hospital
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference40 articles.
1. Inter-pathologist and pathology report agreement for ovarian tumor characteristics in the Nurses' Health Studies;Barnard;Gynecol. Oncol.,2018
2. The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol;Byrd-Leifer;Eur. J Immunol.,2001
3. TLR4 is a novel determinant of the response to paclitaxel in breast cancer;Rajput;Mol. Cancer Ther.,2013
4. TLR4 induces tumor growth and inhibits paclitaxel activity in MyD88-positive human ovarian carcinoma in vitro;Wang;Oncol. Lett.,2014
5. Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway;Huang;Sci. Rep.,2014
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Single-cell transcriptomics reveals subset-specific metabolic profiles underpinning the bronchial epithelial response to flagellin;iScience;2024-09
2. Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics;Frontiers in Oncology;2024-07-15
3. Interferon-γ Induces Interleukin-6 Production and Alpha-smooth Muscle Actin Expression in Systemic Sclerosis Fibroblasts;Iranian Journal of Allergy, Asthma and Immunology;2024-04-14
4. The Role of Cytokines in Activation of Tumour-promoting Pathways and Emergence of Cancer Drug Resistance;Current Topics in Medicinal Chemistry;2024-03
5. Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors;Cancer Drug Resistance;2024-02-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3